Latest Regulatory Approvals News

Orthocell has completed its first Remplir™ surgical case in Hong Kong, marking a pivotal step in its Asian commercialisation strategy. The launch at the Hong Kong Orthopaedic Association Congress and partnership with MontsMed set the stage for broader regional growth.

Eastern Metals is progressing its acquisition of Raptor Resources and has agreed to sell its Browns Reef Project, while planning a $4-5 million capital raise pending shareholder approval.

Bioxyne Limited, through its subsidiary Breathe Life Sciences, has inked an exclusive deal to import, manufacture, and distribute Curaleaf’s Que Medical Inhalation Device in Australia, with a nationwide launch set for November 2025.

Bayan Mining and Minerals has refined its rare earth element targets at the Desert Star Projects in California through detailed geophysical surveys, setting the stage for imminent drilling. The company’s integrated approach highlights structural controls similar to the nearby Mountain Pass district, boosting confidence in the project’s potential.

Aquirian Limited has completed a strategic review of its Wubin Energetics Precinct and entered a framework agreement with Hongda Civil Blasting Group to establish a joint venture for an automated electronic detonator facility in Western Australia.

New Frontier Minerals has finalised drill targets for a maiden reverse circulation program at its Harts Range Heavy Rare Earth and Niobium Project, with regulatory approvals imminent and drilling poised to begin.

Platina Resources has identified five promising target zones at its Mt McKenna Gold Project in Western Australia, setting the stage for imminent drilling after securing key approvals and completing detailed surveys.

Pepper Money and KKR have agreed to acquire Westpac’s RAMS home loan portfolio, marking a significant move in Australia’s mortgage servicing landscape. The $21.4 billion portfolio acquisition aligns with Pepper Money’s strategy to expand its capital-light servicing business.

Westpac has agreed to sell its $21.4 billion RAMS mortgage portfolio to a consortium led by Pepper Money, KKR, and PIMCO, aiming to simplify operations and boost capital ratios despite an expected loss on sale.

Pacific Smiles Group Limited shares will be suspended from ASX trading following compulsory acquisition notices issued by Beam Dental Bidco Pty Ltd, signaling a significant ownership change.

Resources & Energy Group Limited (REZ) has secured approval to expand gold vat leach production at its East Menzies Gold Project, transitioning from trial to commercial scale. The company also announced a maiden JORC 2012 Inferred Mineral Resource at Gigante Grande, underpinning future growth.

Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.